PURPOSE: Multidrug-resistant organisms causing community-acquired and hospital-acquired infections are increasing at a dangerous rate. Carbapenemase-producing Enterobacteriaceae and Pseudomonas species are an important source of concern since these organisms are not only resistant to beta-lactam antibiotics but also show cross-resistance to other groups of antibiotics. In the present study, rapid detection of these carbapenemase-producing Enterobacteriaceae and Pseudomonas species by carbapenemase Nordmann-Poirel (Carba NP) test was evaluated by comparing with modified Hodge test (MHT).
Introduction
M u l t i d r u g -r e s i s t a n t o r g a n i s m s c a u s i n g c o m m u n i t y -a c q u i r e d and hospital-acquired infections are increasing at a dangerous rate globally, especially among Enterobacteriaceae and nonfermenters. [1] Extended-spectrum β -lactamase (ESBL)-and acquired cephalosporinase (AmpC)-producing organisms are resistant to almost all β -l a c t a m s w i t h t h e e x c e p t i o n o f carbapenems. Treatment of choice for these ESBL-or AmpC-producing isolates is carbapenems. [2] Therefore, it is important to preserve the clinical efficacy of carbapenems (imipenem, ertapenem, meropenem, and doripenem). However, in recent times, there is an increase in reporting of carbapenem-resistant Enterobacteriaceae worldwide, probably as a result of carbapenemase gene acquisition [3] resulting in treatment failure due to carbapenem usage. Various mechanisms of carbapenem resistance in Enterobacteriaceae are due to a decrease in bacterial outer-membrane permeability, with excess production of β-lactamases with no carbapenemase activity or expression of carbapenemases. [4, 5] Klebsiella pneumoniae carbapenemase (Ambler Class A); Verona integron-encoded metallo-β-lactamase, imipenemase, and New Delhi metallo-β-lactamase (all Ambler Class B); and oxacillinase-48 (Ambler class D) are some examples of carbapenemases reported in Enterobacteriaceae. [6] Due to other resistance mechanisms, most of the times carbapenemase-producing Enterobacteriaceae and Pseudomonas species show resistance to other groups of drugs also leading to multidrug-resistant or pandrug-resistant isolates. Rampant spread of such isolates is an important source of concern globally. [7] This shows that for the selection of appropriate therapeutic schemes and the implementation of infection control measures, detection of carbapenemase producers is important. [8, 9] Rapid identification of carbapenemase is the need of today's clinical practice. Ultraviolet spectrophotometry, matrix-assisted laser desorption ionization-time of flight technique, and molecular methods are few examples of techniques available for rapid detection. Even though these methods have good sensitivity and specificity, they require trained microbiologists and expensive equipment. Molecular methods which are considered as gold standard method may fail to detect unknown carbapenemase genes not included in gene panel. [10] To overcome all these drawbacks, a biochemical test (carbapenemase Nordmann-Poirel [Carba NP] test) based on a technique designed to identify the hydrolysis of the β-lactam ring of a carbapenem has been developed. [11] The present study was undertaken to evaluate Carba NP test in discriminating carbapenemase producers from nonproducers by comparing with modified Hodge test (MHT).
Materials and Methods
This study was conducted in the department of microbiology of a teaching hospital. Ethical clearance certificate was obtained from the Institutional Ethical Committee. Various samples such as pus, blood, sputum, urine, and endotracheal aspirates received in the laboratory were inoculated on a sterility-checked MacConkey agar and blood agar plates and incubated at 37°C for 18-24 h. Based on the growth on MacConkey agar and blood agar, isolates were further processed in VITEK 2 systems, for identification and antimicrobial susceptibility. Imipenem-resistant Enterobacteriaceae and Pseudomonas species were further processed for carbapenemase production by MHT and Carba NP test. Kappa analysis was done to evaluate the percentage agreement between MHT and Carba NP tests.
Modified Hodge test
Lawn culture of ATCC Escherichia coli 25922 at a turbidity equivalent to that of 0.5 McFarland was made onto the Mueller-Hinton agar plate. After drying, an imipenem (10 µg) disc was placed at the center of the plate. The test strain and control strains (a known carbapenemase-producing Pseudomonas aeruginosa was used as positive control, and E. coli ATCC 25922 was used as negative control) were heavily streaked from the edge of the imipenem disc to the periphery of the plate in different directions. The plates were incubated at 37°C for 18-24 h.
Interpretation
The presence of a cloverleaf type of zone of inhibition near the test/positive control organism was interpreted as MHT positive. [12] Carbapenemase Nordmann-Poirel test
The Carba NP test for Enterobacteriaceae and Pseudomonas spp. was performed as follows: Two 1.5-ml low-bind protein microcentrifuge tubes (Eppendorf), each containing 100 µl of a 20-mM Tris-HCL lysis buffer, were individually inoculated with a 1-µl loopful of bacterial colony (18-24 h old, loop swept through pure culture), and bacterial suspensions were vortexed for 5 min. To the first tube, 100 µl of 0.5% (wt/vol) phenol red solution with 10-mM zinc sulfate (solution A, buffered to pH 7.8 by adding 0.1 N NaOH) was then added, and the tube was vortexed. To the second tube, 100 µl of solution A with imipenem dissolved directly in solution A to a final concentration of 6 mg/ml was added and then vortexed. A mixture of the phenol red solution and the enzymatic suspension being tested was incubated at 37°C for a maximum of 2 h. [13] A known carbapenemase-producing P. aeruginosa was used as positive control, and E. coli ATCC 25922 was used as negative control.
After incubation, the presence of any carbapenemase, which hydrolyzes imipenem into its carboxylic form, leading to a pH decrease, was detected by a color change of phenol red solution (red to yellow/orange), while tubes remain red in the absence of carbapenemase.
1. F i r s t t u b e a n d s e c o n d t u b e r e m a i n i n g red -noncarbapenemase-producing isolate 2. First tube remaining red and second tube turning yellow/orange -carbapenemase-producing isolate. Both Serratia species were negative for carbapenemase production by both the methods. Kappa analysis revealed that the strength of agreement between the two tests is considered very good (kappa = 97%, confidence interval = 0.916-1.00).
Results

Seventy imipenem-resistant
Discussion
One of the greatest advances of modern medicine is the development of antibiotics for the treatment of infectious disease. Unfortunately, effectiveness of many antimicrobial agents is under threat due to the emergence of antibiotic resistance among bacteria. In order to control the emergence of drug resistance, the irrational use of antibiotics should be controlled. [14] reported 87.01% of E. coli and 91.51% of Klebsiella spp. as carbapenemase producers by MHT. These findings suggest that carbapenemase production is on rise in Enterobacteriaceae, particularly in Klebsiella species. 34.48% Pseudomonas species were detected as carbapenemase producers, and similar findings were observed in a study done by ElMasry et al., [15] in which 37% of Pseudomonas species were reported as carbapenemase producers by polymerase chain reaction. However, by MHT, positivity was increased to 48.1%.
One Pseudomonas aeruginosa strain in the present study was positive for carbapenemase production by MHT but negative by Carba NP test. Several studies have shown that GES-type carbapenemase-producing Pseudomonas species may not be detected by Carba NP test. [16] This could be one of the reasons in the present study for Carba NP test showing negative results. However, in this study, molecular analysis was not performed to comment on sensitivity or specificity of Carba NP test.
In the present study, MHT test was performed using imipenem disc instead of ertapenem or meropenem disc because we were able to reproduce and interpret results better using imipenem disc than meropenem. Even though both Carba NP and MHT detected carbapenemase producers almost equally except for one strain which gave negative results with Carba NP test, MHT at times was difficult to interpret. 
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